MedPath

Evaluation of the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures

Phase 4
Completed
Conditions
Femoral Fractures
Interventions
Device: LISS
Device: Plates to treat fractures of the distal femur
Registration Number
NCT00552331
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

The purpose of this study is to determine whether the rate of fracture healing and fracture union, repaired with the LISS device, will be as good as or better than the usual fracture fixation systems.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • The patient has read and agree to the consent
  • Patient is 16 years or older (bones have finished growing)
  • The injury happened in the last 14 days
Exclusion Criteria
  • The patient taking part in another study
  • The patient has an infection at the operative site
  • The patient has a health condition that affects bone healing or interferes with their ability to complete the study requirements (questionnaires, examinations), for example Paget's disease or osteomalacia
  • The patient is taking medication that affects bone healing (such as systemic steroids)
  • The patient has malignant (tumor) disease
  • The patient is unable to attend follow-up clinic visits

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LISSLISSTreatment of distal femur fracture with less invasive stabilization system
Standard TreatmentPlates to treat fractures of the distal femurTreatment of distal femoral fractures using locking condylar plates or dynamic condylar screws
Primary Outcome Measures
NameTimeMethod
Delayed union or nonunion of the distal femur12 months post operative

Determined via radiographic analysis

Secondary Outcome Measures
NameTimeMethod
Time to clinical healing12 months

assessed by weight-bearing ability and pain

Function as assessed by patient6 months, 12 months

Assessed using LEM, SMFA, and SF-36 questionnaires

Frequency of adverse events12 months
Range of motionPost-op, 6 weeks, 3 months, 6 months, 12 months
Gait analysis12 months

Trial Locations

Locations (1)

QEII Health Sciences Centre

🇨🇦

Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath